On Dec 19, the Guangzhou Daily Data and Digital Institute (GDI Think Tank) released the "Guangdong Innovation Rankings (2024) ", which evaluated enterprises in Guangdong with over 50 inventions.
On Dec 17, the Huangpu Social Construction Promotion Association held a members' day event where representatives of well-known enterprises visited the XPeng Aeroht and Minotech headquarters to participate in tours and exchanges.
Fortune magazine recently released the 2024 Global Future 50 list, with Guangzhou WeRide Company from China ranking 26th, making it one of the highest-ranked autonomous driving technology companies on the list.
LAPLACE Renewable Energy Technology Company (LAPLACE) with stock symbol 688726.SH, an investment of Guangzhou Development District (GDD) Industry Fund Investment Group Company, has launched its initial public offering on the SSE STAR Market.
Guangzhou's high-tech enterprises are making significant strides on the global stage, showcasing their innovative prowess and strategic foresight.
Akeso has announced that its PD-1/VEGF dual antibody, Ivonescimab, which is under clinical research, has shown significant advantages over "Keytruda", becoming the world's first drug to demonstrate such effectiveness.
More than twenty years ago, Amway conducted a nationwide factory site selection survey and eventually settled in the Guangzhou Development District (GDD), deeply integrating into the Chinese market.
Guangzhou International Bio Island recently hosted the "Cross-Border Medical Technology CEOs Guangzhou Tour" exchange activity in the Huangpu district.
The leading domestic enterprise in Organic Photovoltaics (OPV), Guangzhou Chasing Light Technology Company, recently signed an agreement to settle in the Kaitou Zhixing Industrial Space in the Huangpu district and Guangzhou High-Tech District.
On Sept 12, Guangzhou SupBio Bio-Technology and Science Company held a product launch event at the Huangpu International Talent Lounge.